Date Published: 17 May 2012

Study of the experiences and needs of people after primary treatment of colorectal cancer

Health News from the United Kingdom (UK).

Southampton University has released information about plans for the first study of its kind to investigate the experiences and needs of people after primary treatment of colorectal cancer (including colon cancer). Researchers from the Macmillan Survivorship Research Group (MSRG), at Southampton University, England, will collect and study data about the experiences and needs of people who have completed treatment for colorectal cancer. Examples of factors influencing recovery that will be part of the research include:

  • the length of time it takes a patient to return to feeling 'well',
  • the length of time symptoms of treatment last, and
  • the range of things people can do to help return to 'normal' more quickly.

Results from this rigorous study will, for the first time, inform health care providers and professionals across the country about what helps or hinders rapid and effective recovery. It will also help identify areas for the development of interventions to aid the recovery process of those who may be at risk of experiencing problems.

More than 1,000 patients have been recruited to the study, one of whom is Susan Restorick-Banks from Totton in Hampshire. Susan was diagnosed with a tumour in her colon in early 2011. She has endured Radiotherapy, surgery to remove the tumour and six months of chemotherapy. She said:

" It's been really important for me to participate in this study. By speaking out and giving my views, I feel I'm contributing to the wellbeing of future cancer survivors and it's really the only way researchers have of finding out how people like me cope.
_Whilst I've had a very supportive network around me, and have continued to enjoy life throughout my treatment, I know that other people going through cancer treatment can experience things very differently
."

Colorectal cancer has been chosen as the focus for the study as it is one of the most treatable cancers in the UK. It affects both men and women equally and can involve all three forms of basic cancer treatment: surgery, chemotherapy and radiotherapy. The participants, of whom 187 are from the Southampton area, will be followed over a two-year period establishing the natural history of the recovery of their health and wellbeing and assessing how quickly they recover after colorectal cancer.

 

Senior Research Fellow at Southampton University and chief investigator for the research Dr Deborah Fenlon said:

" Up until now the general focus for cancer research has been on cure and prevention for the disease. Macmillan is uniquely concerned with helping to improve the lives of people living with cancer, and for us it is absolutely imperative we understand the experiences of the two million cancer survivors in order to positively inform the professionals who interact and support these survivors, helping them get the best out of life once treatment is over."

Professor Jessica Corner, Dean of Health Sciences at Southampton University and Chief Clinician of Macmillan, said,

" As a leading health sciences research-based Faculty, and the only research unit funded by Macmillan, we are extremely proud to be undertaking this radical new research. Our ultimate joint-aim is to help improve the lives of people with cancer by informing health care providers and professionals in practice which help care for the two million plus cancer survivors across the UK. Recruiting more than 1000 patients is a real milestone for the study and we are incredibly grateful to Susan and all those participating and involved in the research."

This study forms part of a trio of research projects being undertaken by Health Sciences researchers from the MSRG. Initial research was conducted into how people manage cancer and cancer-related problems followed by creating and testing an online intervention to support self-management.

Ciarán Devane, Chief Executive of Macmillan Cancer Support, said:

" We are delighted to congratulate our Macmillan Survivorship Research Group in their recruitment of their 1,000th research participant to the CREW research study. Macmillan is committed to understanding and using evidence, to help the 2 million people living with cancer in the UK. Work with our academic colleagues is helping us to increase our knowledge and will allow us to develop our services in the future.
_ The CREW study is important in helping us learn more about bowel cancer patients and their different needs after treatment. The information gained through research will help us support and improve the lives of the increasing numbers of people who are living with and beyond cancer
."

 


News is included on the IvyRose website to inform visitors about current health issues, but not to endorse any particular view or activity. Any views expressed in the article above are not necessarily those of IvyRose Ltd.. Material in this news item was released by the UK-based source listed below on 17 May 2012 and may have been edited (e.g. in style, length, and/or for ease of understanding by our international readers) for inclusion here. For further information, please visit their website.

Source: Southampton University
http://www.soton.ac.uk -

Also in the News:

Acupuncture can help treat lung disease - 17 May '12

Explain the different mechanisms of pain - 14 May '12

Calls for blindness warnings on cigarettes - 1 May '12

A persistent cough may be a sign of lung cancer - 1 May '12

Complementary feeding campaign launched in Cambodia - 27 Apr '12

25 April 2012 is World Malaria Day - 25 Apr '12

Personal exercise regimes to treat depression in young people - 17 Apr '12

Discovery of genes that influence risk of fracture and osteoporosis - 16 Apr '12

Be a secret angel today: How many anonymous good turns can you do in just 24 hours ?

Although care has been taken when compiling this page, the information contained might not be completely up to date. Accuracy cannot be guaranteed. This material is copyright. See terms of use.

IvyRose Holistic 2003-2019.